Mira Pavlovic is specialist in dermatology, regulatory and health technology assessment in Europe. She is a founder of Medicines Development and Training (MDT) services (Paris, France) and Associate Professor for regulatory and HTA science at Lisbon University, Portugal. In addition to dermatology and aesthetic dermatology activities, Mira served as a Head of Scientific Advice at the French Medicines Agency (ANSM) and was member of several working parties at the European Medicines Agency. In 2010 Mira joined the Hauté Autorité de Santé (HAS), France, as Deputy Director for Health Technology Assessment and international affairs, in charge of European activities related to relative effectiveness assessment for reimbursement purposes. Since September 2015 she consults on clinical drug development strategies and teaches regulatory and HTA science at the University of Lisbon.